AgelessRx announced the introduction of Tadalafil Daily, a new offering positioned as part of its broader strategy to enhance healthspan. According to the company, the daily low-dose formulation is intended to support vascular health, which plays a key role in age-related conditions.
The company said tadalafil, commonly prescribed for erectile dysfunction, has additional effects on endothelial function and blood flow that may benefit cardiovascular health. AgelessRx claims the daily regimen is based on emerging evidence suggesting potential protective effects beyond its approved use.
According to the company, Tadalafil Daily will be available through its telemedicine platform following an evaluation by licensed healthcare providers. AgelessRx said the product launch aligns with its mission to deliver science-backed interventions that target underlying aging processes rather than symptoms alone.
The company claims that improving vascular function may help mitigate risks associated with hypertension, cognitive decline and other chronic conditions linked to aging. AgelessRx also noted it will continue to expand its portfolio with therapies designed to promote longevity and improve quality of life.
AgelessRx said it remains focused on translating scientific research into accessible clinical solutions, aiming to extend the healthy, functional years of life for its users.
